HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Ito Selected Research

Platypnea Orthodeoxia Syndrome

4/2018Platypnea-orthodeoxia Syndrome Induced by Multiple Vertebral Compression Fractures and an Atrial Septal Defect.
7/2014Transcatheter closure of right-to-left atrial shunt in patients with platypnea-orthodeoxia syndrome associated with aortic elongation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Ito Research Topics

Disease

44Neoplasms (Cancer)
12/2021 - 01/2002
43Heart Failure
03/2022 - 02/2005
31Myocardial Infarction
05/2022 - 01/2003
25Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 01/2011
24Infections
02/2022 - 04/2002
22Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2003
22Hypertension (High Blood Pressure)
11/2021 - 04/2007
21Inflammation (Inflammations)
06/2022 - 01/2002
17Pulmonary Arterial Hypertension
01/2021 - 05/2010
16Atrial Fibrillation
01/2022 - 05/2003
14Hypertrophy
05/2019 - 08/2002
14Schizophrenia (Dementia Praecox)
11/2017 - 02/2008
13Diabetes Mellitus
05/2022 - 01/2003
12Stroke (Strokes)
03/2022 - 02/2004
12Thrombosis (Thrombus)
01/2022 - 09/2004
12Pulmonary Hypertension
01/2022 - 02/2009
11Insulin Resistance
03/2022 - 09/2009
11Atherosclerosis
01/2022 - 04/2006
11Cardiomegaly (Heart Hypertrophy)
05/2019 - 08/2002
10Fibrosis (Cirrhosis)
04/2021 - 08/2009
10Chronic Renal Insufficiency
01/2019 - 01/2011
10Ischemia
06/2017 - 08/2003
9Type 2 Diabetes Mellitus (MODY)
02/2022 - 07/2014
9Hemorrhage
01/2022 - 01/2005
9Wounds and Injuries (Trauma)
12/2021 - 09/2002
8Periodontitis
04/2022 - 12/2016
8Acute Coronary Syndrome
01/2022 - 02/2004
8Stable Angina
02/2021 - 02/2007
8Body Weight (Weight, Body)
01/2021 - 02/2014
8Hypoxia (Hypoxemia)
01/2018 - 08/2002
8Familial Primary Pulmonary Hypertension
12/2016 - 01/2010
8Infarction (Infarctions)
06/2012 - 01/2003
7Pathologic Constriction (Stenosis)
12/2022 - 06/2008
7Rheumatoid Arthritis
02/2022 - 02/2011
7Alzheimer Disease (Alzheimer's Disease)
02/2021 - 11/2008
7Left Ventricular Dysfunction
01/2021 - 01/2011
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 12/2011
7Necrosis
12/2016 - 07/2004
6Sarcoidosis (Schaumann Disease)
02/2022 - 09/2014
6Hypotension (Low Blood Pressure)
11/2021 - 01/2011
6Atrial Heart Septal Defects (Atrial Septal Defect)
05/2021 - 01/2012
6Hypertriglyceridemia
05/2019 - 08/2011
6Ventricular Fibrillation
05/2019 - 10/2010
6Neoplasm Metastasis (Metastasis)
01/2018 - 05/2003
6Mental Disorders (Mental Disorder)
01/2017 - 10/2005
6Pancreatic Neoplasms (Pancreatic Cancer)
11/2014 - 10/2003
5Myocardial Ischemia (Ischemic Heart Diseases)
03/2022 - 11/2003
5Hyperglycemia
01/2021 - 01/2003

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2007
20Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2022 - 09/2005
19Pharmaceutical PreparationsIBA
01/2021 - 04/2002
12Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2002
12Epoprostenol (Prostacyclin)FDA LinkGeneric
11/2019 - 10/2010
10Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2003
10Oxygen (Dioxygen)IBA
01/2022 - 06/2002
10LipidsIBA
01/2021 - 03/2006
9CalciumIBA
06/2022 - 12/2012
9Dopamine (Intropin)FDA LinkGeneric
06/2014 - 09/2006
8CytokinesIBA
04/2022 - 03/2004
8Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 07/2009
8Angiotensin Receptor AntagonistsIBA
03/2019 - 04/2006
8C-Reactive ProteinIBA
01/2018 - 09/2005
7SteroidsIBA
01/2022 - 05/2006
7LDL CholesterolIBA
12/2020 - 02/2013
7Eicosapentaenoic AcidIBA
06/2018 - 10/2014
7Antipsychotic Agents (Antipsychotics)IBA
11/2017 - 05/2010
6oxidized low density lipoproteinIBA
05/2022 - 02/2013
6Messenger RNA (mRNA)IBA
01/2022 - 08/2002
6Therapeutic UsesIBA
10/2021 - 10/2003
6Nicorandil (SG 75)IBA
02/2021 - 04/2003
6MonocrotalineIBA
01/2021 - 02/2009
6MetalsIBA
02/2018 - 02/2003
6Angiotensin IIIBA
06/2017 - 04/2006
5voglibose (Basen)IBA
01/2022 - 07/2014
5AntibodiesIBA
01/2022 - 01/2003
5AnticoagulantsIBA
01/2022 - 08/2011
5DiureticsIBA
01/2022 - 01/2012
5CreatinineIBA
02/2021 - 01/2016
5CatecholaminesIBA
01/2021 - 10/2006
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2020 - 08/2002
53- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
01/2020 - 02/2018
5SmokeIBA
11/2019 - 10/2011
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2019 - 01/2010
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 04/2006
5LigandsIBA
12/2018 - 05/2010
5Cystatin CIBA
09/2018 - 07/2013
5Gefitinib (Iressa)FDA Link
11/2017 - 02/2014

Therapy/Procedure

99Therapeutics
04/2022 - 04/2002
34Percutaneous Coronary Intervention
05/2022 - 04/2003
12Stents
02/2022 - 01/2005
12Drug Therapy (Chemotherapy)
01/2022 - 11/2004
12Hepatectomy
10/2019 - 10/2003
10Ligation
04/2022 - 01/2003
10Catheter Ablation
01/2022 - 10/2017
9Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2017 - 11/2010
7Catheters
04/2022 - 07/2011
7Hip Replacement Arthroplasty (Total Hip Replacement)
02/2013 - 09/2003
6Lasers (Laser)
08/2014 - 12/2008
6Osteotomy
08/2006 - 07/2004